Evidence map›Paper›PMID 41715088›Full record

ArticleMicrobial cell factories2026

Escherichia coli BL21 adapts its central carbon metabolism to recombinant protein production and oxygen limitation.

Divyata Vilas Rane, Karen Lund Haaland, Åse Refsnes, Hege Skuggedal, Stinus Reklev Øverbø, Per Bruheim, Laura García-Calvo

Abstract read
In one paragraph

Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Divyata Vilas RaneDepartment of Biotechnology and Food Science, NTNU Norwegian University of Science and Technology, Trondheim, Norway.
Karen Lund HaalandDepartment of Biotechnology and Food Science, NTNU Norwegian University of Science and Technology, Trondheim, Norway.
Åse RefsnesDepartment of Biotechnology and Food Science, NTNU Norwegian University of Science and Technology, Trondheim, Norway.
Hege SkuggedalDepartment of Biotechnology and Food Science, NTNU Norwegian University of Science and Technology, Trondheim, Norway.
Stinus Reklev ØverbøDepartment of Biotechnology and Food Science, NTNU Norwegian University of Science and Technology, Trondheim, Norway.
Per BruheimDepartment of Biotechnology and Food Science, NTNU Norwegian University of Science and Technology, Trondheim, Norway. per.bruheim@ntnu.no.
Laura García-CalvoDepartment of Biotechnology and Food Science, NTNU Norwegian University of Science and Technology, Trondheim, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh-yielding recombinant protein expression systems often face challenges due to the metabolic burden caused by the competition for cellular resources, resulting in reduced growth and, hence, limiting their industrial applicability. Furthermore, industrial recombinant protein production is also affected by the occurrence of oxygen gradients, which is a prevalent issue in large-scale bioreactors. These gradients create a heterogeneous environment in the bioreactor, which affects cell growth and metabolism, having severe consequences on the process performance. Both these factors alter cellular physiology and metabolism, thereby affecting recombinant protein yields. Understanding metabolic adaptations to these stress conditions is crucial for uncovering the underlying cellular mechanisms, which can direct further optimization of the recombinant strains. In this study, we aimed to explore the combined response of the central metabolism of Escherichia coli to metabolic burden and microaerobic conditions. Two recombinant protein-producing E. coli BL21 strains carrying XylS/Pm vectors with low (A2-mCh) and medium plasmid copy numbers (A3-mCh), and producing mCherry protein, were studied by introducing oxygen limitation. Central metabolite pools were analyzed by three targeted LC-MS/MS methods, using the isotope dilution strategy for absolute quantification.

resultsBoth recombinant strains exhibited different levels of metabolic burden, with the strain possessing a higher plasmid copy number showing more pronounced growth retardation and a stronger impact on metabolite pools. Both strains, however, showed a similar response to oxygen limitation, with significant adaptations in the central metabolite pools. The low plasmid copy number strain showed an increase in the concentration of lower glycolytic and tricarboxylic acid cycle metabolites, while the pools of upper glycolytic and pentose phosphate pathways and nucleoside phosphates were mostly unaffected. However, a more extreme response was seen in A3-mCh, where the majority of the metabolite pools were increased. Oxygen limitation caused lower metabolic activity, but the energy charge and redox balance were maintained, and no negative effect was observed on mCherry production rates.

conclusionThis study provides insights into metabolic adaptations in E. coli BL21 recombinant strains, having quite robust mechanisms to maintain intracellular metabolic homeostasis during both internal and external perturbations.

Indexed as

CarbonEscherichia coliOxygenRecombinant ProteinsBioreactorsPlasmidsCarbonOxygenRecombinant ProteinsCentral carbon metabolomeEscherichia coliMetabolic burdenMicroaerobic conditionsRecombinant protein production

Identifiers

PMID41715088
PMCPMC13020385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.